1 / 9

Genome (DNA) Sequencing Market Trends and Analysis

The global Genome (DNA) Sequencing Market size is predicted to reach USD 42.28 billion with a CAGR of 22% by 2030 .

Sanyukta2
Download Presentation

Genome (DNA) Sequencing Market Trends and Analysis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Genome (DNA) Sequencing Market The Genome (DNA) Sequencing Market is predicted to reach USD 42.28 billion with a CAGR of 22% by 2030. Market Key Segments - By Application Next Move Strategy Consulting

  2. 01 02 03 04 05 Table Of Market Overview Content Market Segmentation Regional Analysis Key Market Players Key Highlights Next Move Strategy Consulting

  3. Market Overview • Genome (DNA) sequencing refers to a technology that enables the sequencing of multiple • DNA strands through massive parallelism. • It is the process of analyzing the sample of DNA that is taken from blood and extracts DNA & prepares for sequencing. • This technology sequences the entire genome of an organism to help identify the order or sequence of DNA nucleotides or bases encoded by letters such as adenine (A), cytosine (C), guanine (G), and thymine (T) among others. • The study of DNA sequencing is widely used in areas, such as biomarker discovery, oncology studies, personalized medicine, forensics, and others. • Genome sequencing also provides information about drug efficacy or adverse effects of drug. • This technology offers low cost, high accuracy & speed and accurate results even with • small sample inputs. • The rising prevalence of genetic diseases such as cancer, alzheimer's, and cystic fibrosis amplified the requirement for genome sequencing, enabling the identification of genetic mutations driving these conditions and facilitating the development of personalized • treatments, thereby propelling the growth of the genome sequencing market. Next Move Strategy Consulting

  4. Market Segmentation • By Product Type • Consumable • Instrument • Service • By Technology • Sequencing by Synthesis • Ion Semiconductor Sequencing • Sequencing by Ligation • Pyrosequencing • Single Molecule Real-time Sequencing • Chain Termination Sequencing • Nanopore Sequencing • By Application • Biomarkers and Cancer • Research • Diagnostics • Reproductive Health • Personalized Medicine • Forensics • Agriculture & Animal Research • Others Next Move Strategy Consulting

  5. Market Segmentation • By Type • Whole Genome Sequencing • Exome Sequencing • Targeted Sequencing • By End User • Academic & Government Research Institutes • Pharmaceutical Companies • Biotechnology Companies • Hospitals & Clinics • Others Next Move Strategy Consulting

  6. Regional Analysis • North America • The U.S. • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Rest of Asia-Pacific • RoW • UAE • Saudi Arabia • South Africa • Brazil • Remaining Countries • Europe • The UK • Germany • France • Italy • Spain • Denmark • Netherlands • Finland • Sweden • Norway • Russia Next Move Strategy Consulting

  7. Key Market Players • Illumina Inc. • Thermo Fischer Scientific Inc. • Oxford Nanopore Technologies Plc • Agilent Technologies • PerkinElmer Inc. • QIAGEN • Eurofins Scientific • Takara Bio Inc. • Hamilton Company Next Move Strategy Consulting

  8. Key Highlights • Market Growth : The market has been expanding rapidly, driven by advances in technology, decreasing costs, and increased applications in personalized medicine, genomics research, and biotechnology. • Technological Advancements : Innovations such as Next-Generation Sequencing • (NGS) and single-cell sequencing are enhancing throughput, accuracy, and speed. • These technologies are making sequencing more accessible and affordable. • Increasing Investments : Venture capital and government funding are flowing into genomics research and sequencing technologies, fostering innovation and new • product development. • Collaborations and Partnerships : There is a trend of collaborations among academic institutions, research organizations, and biotech companies to leverage expertise and accelerate advancements in sequencing technologies. • Ethical Considerations : As sequencing becomes more prevalent, ethical concerns regarding privacy, data security, and the implications of genetic information are • gaining attention. Next Move Strategy Consulting

  9. Follow us THANK YOU Next Move Strategy Consulting www.nextmsc.com info@nextmsc.com +1-217-650-7991 Access Full Report - https://www.nextmsc.com/report/genome-dna-sequencing-market Next Move Strategy Consulting

More Related